Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $118M (100.0% shares, 0.0% debt)

Holdings (17)

— Corbus Pharmaceuticals HLDGS 25.8%

Value $30.47M Shares 4,062,791 Est. Cost $4.54 Unrealized —

— Abeona Therapeutics Inc 25.1%

Value $29.64M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Biohaven Pharmactl Hldg Co L 23.6%

Value $27.92M Shares 749,815 Est. Cost $25.00 Unrealized —

ALDX Aldeyra Therapeutics Inc 5.3%

Value $6.317M Shares 484,096 Est. Cost $8.65 Unrealized -6.2%

— Electrocore Inc 4.8%

Value $5.667M Shares 396,825 Est. Cost $16.51 Unrealized —

KRYS Krystal Biotech Inc 4.3%

Value $5.103M Shares 300,000 Est. Cost $10.08 Unrealized +66.4%

— Galmed Pharmaceuticals Ltd 2.4%

Value $2.881M Shares 210,000 Est. Cost $11.90 Unrealized —

ENTX Entera Bio Ltd 2.0%

Value $2.406M Shares 475,540 Est. Cost $6.29 Unrealized -12.7%

AVXL Anavex Life Sciences Corp 1.6%

Value $1.868M Shares 724,205 Est. Cost $3.56 Unrealized -20.8%

— Soligenix Inc. 1.3%

Value $1.525M Shares 837,800 Est. Cost $2.11 Unrealized —

— Vascular Biogenics LTD 1.3%

Value $1.489M Shares 896,771 Est. Cost $4.71 Unrealized —

VNRX Volition RX LTD 0.8%

Value $916K Shares 321,413 Est. Cost $3.75 Unrealized -45.2%

— Eiger Biopharmaceuticals Inc 0.8%

Value $910K Shares 75,238 Est. Cost $9.85 Unrealized —

— Evoke Pharma Inc 0.7%

Value $825K Shares 275,000 Est. Cost $2.99 Unrealized —

NAGE Chromadex Corp 0.2%

Value $192K Shares 47,866 Est. Cost $3.80 Unrealized +13.2%

— Catasys Inc 0.1%

Value $102K Shares 9,081 Est. Cost $6.72 Unrealized —

— Lipocine Inc New 0.1%

Value $69,000 Shares 50,000 Est. Cost $1.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	4,062,791	$30.47M	25.8%	$4.54	—	COM	21833P103
—	Abeona Therapeutics Inc	2,359,767	$29.64M	25.1%	$4.97	—	COM	00289Y107
—	Biohaven Pharmactl Hldg Co L	749,815	$27.92M	23.6%	$25.00	—	COM	G11196105
ALDX	Aldeyra Therapeutics Inc	484,096	$6.317M	5.3%	$8.65	-6.2%	COM	01438T106
—	Electrocore Inc	396,825	$5.667M	4.8%	$16.51	—	COM	28531P103
KRYS	Krystal Biotech Inc	300,000	$5.103M	4.3%	$10.08	+66.4%	COM	501147102
—	Galmed Pharmaceuticals Ltd	210,000	$2.881M	2.4%	$11.90	—	SHS	M47238106
ENTX	Entera Bio Ltd	475,540	$2.406M	2.0%	$6.29	-12.7%	SHS	M40527109
AVXL	Anavex Life Sciences Corp	724,205	$1.868M	1.6%	$3.56	-20.8%	COM NEW	032797300
—	Soligenix Inc.	837,800	$1.525M	1.3%	$2.11	—	COM	834223307
—	Vascular Biogenics LTD	896,771	$1.489M	1.3%	$4.71	—	COM	M96883109
VNRX	Volition RX LTD	321,413	$916K	0.8%	$3.75	-45.2%	COM	928661107
—	Eiger Biopharmaceuticals Inc	75,238	$910K	0.8%	$9.85	—	COM	28249U105
—	Evoke Pharma Inc	275,000	$825K	0.7%	$2.99	—	COM	30049G104
NAGE	Chromadex Corp	47,866	$192K	0.2%	$3.80	+13.2%	COM NEW	171077407
—	Catasys Inc	9,081	$102K	0.1%	$6.72	—	COM	149049504
—	Lipocine Inc New	50,000	$69,000	0.1%	$1.30	—	COM	53630X104